• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The ICF Classification System to Assess Risk Factors for CVD in Secondary Prevention after Ischemic Stroke and Intracerebral Hemorrhage.ICF 分类系统评估缺血性卒中和脑出血后二级预防中 CVD 的危险因素。
Medicina (Kaunas). 2021 Feb 24;57(3):190. doi: 10.3390/medicina57030190.
2
Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF.使用国际功能、残疾和健康分类评估缺血性中风后二级预防的心血管危险因素。
Int J Environ Res Public Health. 2022 Mar 12;19(6):3368. doi: 10.3390/ijerph19063368.
3
Risk Factors for the Recurrence of CVD Incidents in Post-Stroke Patients over a 5-Year Follow-Up Period Based on the ICF Classification.基于国际功能、残疾和健康分类的脑卒中患者 5 年随访期间 CVD 事件复发的危险因素。
Int J Environ Res Public Health. 2021 Jun 3;18(11):6021. doi: 10.3390/ijerph18116021.
4
Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?在患有心房颤动的患者中,哪些风险因素与缺血性卒中的相关性大于脑出血?
Stroke. 2012 Aug;43(8):2048-54. doi: 10.1161/STROKEAHA.112.654145. Epub 2012 May 22.
5
How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?患有缺血性中风或自发性脑出血的抗凝心房颤动患者有何不同?
Clin Cardiol. 2018 May;41(5):608-614. doi: 10.1002/clc.22935. Epub 2018 May 10.
6
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.急性缺血性卒中合并心房颤动患者的早期复发与脑出血:抗凝治疗及其时机的影响:RAF研究
Stroke. 2015 Aug;46(8):2175-82. doi: 10.1161/STROKEAHA.115.008891. Epub 2015 Jun 30.
7
Risk of Stroke After the International Classification of Diseases-Ninth Revision Discharge Code Diagnosis of Hypertensive Encephalopathy.国际疾病分类第九版(ICD-9)出院编码诊断为高血压脑病后的卒中风险
Stroke. 2016 Feb;47(2):372-5. doi: 10.1161/STROKEAHA.115.011992. Epub 2016 Jan 7.
8
Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.抗高血压药物在卒中后的应用差异:来自澳大利亚卒中临床登记的关联数据。
Stroke. 2019 Dec;50(12):3592-3599. doi: 10.1161/STROKEAHA.119.026823. Epub 2019 Oct 25.
9
New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial.新型缺血性卒中与沃拉帕沙和安慰剂的疗效:TRA 2 °P-TIMI 50 试验结果。
J Am Coll Cardiol. 2014 Dec 9;64(22):2318-26. doi: 10.1016/j.jacc.2014.07.997. Epub 2014 Dec 1.
10
Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack.他汀类药物与既往有缺血性卒中或短暂性脑缺血发作患者的脑出血风险
Stroke. 2017 Dec;48(12):3245-3251. doi: 10.1161/STROKEAHA.117.019141. Epub 2017 Oct 25.

引用本文的文献

1
Disabling tinnitus and third nerve palsy following pontine hemorrhage: Application of ICF framework.脑桥出血后耳鸣失能与动眼神经麻痹:国际功能、残疾和健康分类(ICF)框架的应用
Clin Case Rep. 2024 Jan 30;12(2):e8405. doi: 10.1002/ccr3.8405. eCollection 2024 Feb.
2
Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF.使用国际功能、残疾和健康分类评估缺血性中风后二级预防的心血管危险因素。
Int J Environ Res Public Health. 2022 Mar 12;19(6):3368. doi: 10.3390/ijerph19063368.
3
Risk Factors for the Recurrence of CVD Incidents in Post-Stroke Patients over a 5-Year Follow-Up Period Based on the ICF Classification.基于国际功能、残疾和健康分类的脑卒中患者 5 年随访期间 CVD 事件复发的危险因素。
Int J Environ Res Public Health. 2021 Jun 3;18(11):6021. doi: 10.3390/ijerph18116021.

本文引用的文献

1
Secondary prevention and cardiovascular care across Europe: A survey of European Society of Cardiology members' views.欧洲二级预防和心血管护理:欧洲心脏病学会会员观点调查。
Eur J Cardiovasc Nurs. 2020 Mar;19(3):201-211. doi: 10.1177/1474515119877999. Epub 2019 Sep 27.
2
Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.非维生素 K 拮抗剂口服抗凝剂相关脑出血的特征。
Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.
3
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.依洛尤单抗与急性冠脉综合征后的心血管结局。
N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.
4
Stroke-related epilepsy.与中风相关的癫痫。
Eur J Neurol. 2019 Jan;26(1):18-e3. doi: 10.1111/ene.13813. Epub 2018 Oct 15.
5
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.饮酒风险阈值:83 项前瞻性研究中 599912 名当前饮酒者的个体参与者数据的综合分析。
Lancet. 2018 Apr 14;391(10129):1513-1523. doi: 10.1016/S0140-6736(18)30134-X.
6
Treatment of hypertension: The ESH/ESC guidelines recommendations.高血压治疗:ESH/ESC 指南建议。
Pharmacol Res. 2018 Feb;128:315-321. doi: 10.1016/j.phrs.2017.10.003. Epub 2017 Oct 27.
7
Smoking cessation and outcome after ischemic stroke or TIA.缺血性中风或短暂性脑缺血发作后的戒烟与预后
Neurology. 2017 Oct 17;89(16):1723-1729. doi: 10.1212/WNL.0000000000004524. Epub 2017 Sep 8.
8
Mechanical thrombectomy in acute stroke - Five years of experience in Poland.急性脑卒中的机械取栓术-波兰五年的经验。
Neurol Neurochir Pol. 2017 Sep-Oct;51(5):339-346. doi: 10.1016/j.pjnns.2017.05.004. Epub 2017 Jul 5.
9
Carotid endarterectomy for symptomatic carotid stenosis.有症状颈动脉狭窄的颈动脉内膜切除术
Cochrane Database Syst Rev. 2017 Jun 7;6(6):CD001081. doi: 10.1002/14651858.CD001081.pub3.
10
Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.心房颤动诊断时机、动态心电图监测的应用与复发性卒中风险
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). doi: 10.1161/CIRCOUTCOMES.116.002864.

ICF 分类系统评估缺血性卒中和脑出血后二级预防中 CVD 的危险因素。

The ICF Classification System to Assess Risk Factors for CVD in Secondary Prevention after Ischemic Stroke and Intracerebral Hemorrhage.

机构信息

Department of Cardiology, Hospital Center of the Jelenia Góra Valley, 58-506 Jelenia Góra, Poland.

Department of Rehabilitation and Physiotherapy, University of Medical Sciences, 60-545 Poznań, Poland.

出版信息

Medicina (Kaunas). 2021 Feb 24;57(3):190. doi: 10.3390/medicina57030190.

DOI:10.3390/medicina57030190
PMID:33668265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7996308/
Abstract

Patients with a history of prior stroke have a high risk for subsequent cardiovascular events (CVD). Therefore, the implementation of an effective strategy to reduce risk factors and thereby improve secondary prevention outcomes is crucial in this patient population. The aim of this study was to determine differences in the incidence of risk factors for recurrent CVD events based on clinical type of prior stroke and to characterize them using the ICF (International Classification of Functioning, Disability and Health) classification system. The incidence of risk factors for recurrent CVD events were retrospectively analyzed in 109 patients with a history of ischemic stroke (IS) and 80 patients with a history of intracerebral (ICH) within 14 days poststroke. Atrial fibrillation/flutter ( = 0.031), >70% carotid artery stenosis ( = 0.004), blood pressure >140/90 mmHg ( = 0.025), blood HbA1c levels >7% ( = 0.002), smoking ( = 0.026) and NSAID (nonsteroidal anti-inflammatory drug) use ( < 0.001) were significantly more common in patients with a history of ischemic stroke. However, liver function test abnormalities were observed more commonly in patients with a history of hemorrhagic stroke ( = 0.025). The incidence and type of risk factors for recurrent CVD events vary according to the clinical type of prior stroke. The ICF classification system is a useful tool for evaluating these risk factors. This may help reduce the risk of subsequent CVD events.

摘要

患有既往卒中史的患者发生后续心血管事件(CVD)的风险较高。因此,在该患者人群中实施有效的策略来降低风险因素,从而改善二级预防结局至关重要。本研究的目的是确定基于既往卒中的临床类型,复发 CVD 事件风险因素的发生率存在差异,并使用国际功能、残疾和健康分类(ICF)分类系统对其进行特征描述。 对 109 例缺血性卒中(IS)病史和 80 例颅内出血(ICH)病史患者卒中后 14 天内的复发 CVD 事件风险因素的发生率进行回顾性分析。 心房颤动/扑动( = 0.031)、颈动脉狭窄>70%( = 0.004)、血压>140/90 mmHg( = 0.025)、血 HbA1c 水平>7%( = 0.002)、吸烟( = 0.026)和 NSAID(非甾体抗炎药)使用( < 0.001)在有 IS 病史的患者中更为常见。然而,肝功能检查异常在有出血性卒中病史的患者中更为常见( = 0.025)。 复发 CVD 事件的风险因素的发生率和类型根据既往卒中的临床类型而有所不同。ICF 分类系统是评估这些风险因素的有用工具。这可能有助于降低随后发生 CVD 事件的风险。